A detailed history of Fil LTD transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Fil LTD holds 1,607,360 shares of TEVA stock, worth $35.5 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,607,360
Previous 2,118,996 24.15%
Holding current value
$35.5 Million
Previous $34.4 Million 15.88%
% of portfolio
0.03%
Previous 0.04%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$15.81 - $18.96 $8.09 Million - $9.7 Million
-511,636 Reduced 24.15%
1,607,360 $29 Million
Q2 2024

Aug 13, 2024

SELL
$12.78 - $17.4 $3.55 Million - $4.83 Million
-277,587 Reduced 11.58%
2,118,996 $34.4 Million
Q1 2024

May 13, 2024

BUY
$10.67 - $14.43 $709,426 - $959,421
66,488 Added 2.85%
2,396,583 $33.8 Million
Q4 2023

Feb 13, 2024

BUY
$8.12 - $10.63 $6.16 Million - $8.06 Million
758,432 Added 48.26%
2,330,095 $24.3 Million
Q3 2023

Nov 13, 2023

BUY
$7.48 - $10.7 $4.92 Million - $7.04 Million
658,380 Added 72.09%
1,571,663 $16 Million
Q2 2023

Aug 11, 2023

BUY
$7.2 - $9.47 $1.59 Million - $2.1 Million
221,298 Added 31.98%
913,283 $6.88 Million
Q1 2023

May 11, 2023

BUY
$8.36 - $11.37 $2.22 Million - $3.03 Million
266,143 Added 62.5%
691,985 $6.12 Million
Q4 2022

Feb 13, 2023

BUY
$7.95 - $9.48 $624,790 - $745,033
78,590 Added 22.63%
425,842 $3.88 Million
Q3 2022

Nov 10, 2022

BUY
$6.86 - $11.95 $408,677 - $711,909
59,574 Added 20.71%
347,252 $2.8 Million
Q2 2022

Aug 12, 2022

BUY
$7.38 - $10.4 $645,816 - $910,093
87,509 Added 43.72%
287,678 $2.16 Million
Q1 2022

May 13, 2022

BUY
$7.33 - $9.39 $844,056 - $1.08 Million
115,151 Added 135.44%
200,169 $1.88 Million
Q4 2021

Feb 14, 2022

SELL
$7.9 - $10.19 $9,298 - $11,993
-1,177 Reduced 1.37%
85,018 $681,000
Q3 2021

Nov 15, 2021

SELL
$8.38 - $10.18 $52,802 - $64,144
-6,301 Reduced 6.81%
86,195 $840,000
Q2 2021

Aug 13, 2021

BUY
$9.9 - $11.56 $194,327 - $226,911
19,629 Added 26.94%
92,496 $916,000
Q1 2021

May 14, 2021

BUY
$10.34 - $12.81 $175,221 - $217,078
16,946 Added 30.3%
72,867 $841,000
Q4 2020

Feb 08, 2021

BUY
$8.61 - $11.04 $42,085 - $53,963
4,888 Added 9.58%
55,921 $540,000
Q3 2020

Nov 13, 2020

SELL
$8.57 - $12.69 $77,781 - $115,174
-9,076 Reduced 15.1%
51,033 $460,000
Q2 2020

Aug 13, 2020

SELL
$8.12 - $13.12 $139,664 - $225,664
-17,200 Reduced 22.25%
60,109 $742,000
Q1 2020

May 14, 2020

BUY
$6.69 - $13.45 $12,108 - $24,344
1,810 Added 2.4%
77,309 $695,000
Q4 2019

Feb 07, 2020

BUY
$6.53 - $10.72 $46,265 - $75,951
7,085 Added 10.36%
75,499 $740,000
Q3 2019

Nov 13, 2019

BUY
$6.16 - $9.6 $36,812 - $57,369
5,976 Added 9.57%
68,414 $471,000
Q1 2019

May 13, 2019

BUY
$15.58 - $20.01 $968,343 - $1.24 Million
62,153 Added 21808.07%
62,438 $979,000
Q4 2018

Feb 13, 2019

BUY
$14.59 - $23.84 $1,692 - $2,765
116 Added 68.64%
285 $4,000
Q3 2018

Nov 09, 2018

BUY
$21.06 - $25.65 $3,559 - $4,334
169 New
169 $4,000
Q3 2017

Nov 13, 2017

SELL
$15.41 - $32.17 $215,231 - $449,318
-13,967 Closed
0 $0
Q2 2017

Aug 29, 2017

BUY
N/A
13,967
13,967 $464,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $24.5B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Fil LTD Portfolio

Follow Fil LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fil LTD with notifications on news.